Free Trial

G1 Therapeutics (GTHX) Insider Trading & Ownership

$7.15
0.00 (0.00%)
(As of 09/18/2024)

G1 Therapeutics (NASDAQ:GTHX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.11%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$442,014.23
Get GTHX Insider Trade Alerts

Want to know when executives and insiders are buying or selling G1 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GTHX Insider Buying and Selling by Quarter

G1 Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/5/2024Andrew PerryInsiderSell1,337$2.51$3,355.87  
7/5/2024John E (Jack) Jr. BaileyCEOSell7,662$2.51$19,231.62  
7/5/2024John W V UmsteadCFOSell527$2.51$1,322.77  
7/5/2024Terry L MurdockCOOSell2,475$2.51$6,212.25  
5/23/2024Monica R ThomasInsiderSell5,826$4.27$24,877.02  
3/18/2024John W V UmsteadCFOSell6,547$3.02$19,771.94  
Bigger Than Nvidia? (Ad)

Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that's all they'll talk about.

Go here now for this breaking story.
2/12/2024Rajesh MalikInsiderSell28,600$4.62$132,132.00  
1/4/2024John W V UmsteadCFOSell111$2.94$326.34  
1/4/2024Terry L MurdockCOOSell721$2.94$2,119.74  
1/3/2024Rajesh MalikInsiderSell3,019$3.12$9,419.28  
1/2/2024John E (Jack) Jr. BaileyCEOSell32,983$3.27$107,854.41  
12/11/2023Rajesh MalikInsiderSell33,839$3.41$115,390.99  
(Data available from 1/1/2013 forward)

GTHX Insider Trading Activity - Frequently Asked Questions

The list of insiders at G1 Therapeutics includes Andrew Perry, James S Hanson, Jennifer K Moses, John E (Jack) Jr. Bailey, John W V Umstead, Mark A Velleca, Monica R Thomas, Rajesh Malik, and Terry L Murdock. Learn more on insiders at GTHX.

6.11% of G1 Therapeutics stock is owned by insiders. Learn more on GTHX's insider holdings.

The following insiders have sold GTHX shares in the last 24 months: Andrew Perry ($8,801.22), Jennifer K Moses ($9,145.62), John E (Jack) Jr. Bailey ($321,058.73), John W V Umstead ($21,421.05), Mark A Velleca ($175,500.00), Monica R Thomas ($24,877.02), Rajesh Malik ($256,942.27), and Terry L Murdock ($15,610.33).

Insiders have sold a total of 178,289 G1 Therapeutics shares in the last 24 months for a total of $833,356.24 sold.



This page (NASDAQ:GTHX) was last updated on 10/10/2024 by MarketBeat.com Staff
From Our Partners